---
figid: PMC9437968__mmr-26-04-12828-g00
pmcid: PMC9437968
image_filename: mmr-26-04-12828-g00.jpg
figure_link: /pmc/articles/PMC9437968/figure/f1-mmr-26-04-12828/
number: Figure 1
figure_title: ''
caption: Ori improves the clinical symptoms in DSS-induced UC mice. (A) Chemical formula
  of Ori. (B) Daily body weight change in mice 7 days after the beginning of treatment.
  (C) DAI score of the mice. *P<0.05, **P<0.01, ***P<0.001. DSS, dextran sulfate sodium;
  UC, ulcerative colitis; DAI, disease activity index; Ori, oridonin; H, high-dose;
  L, low-dose.
article_title: Oridonin attenuates dextran sulfate sodium-induced ulcerative colitis
  in mice via the Sirt1/NF-κB/p53 pathway.
citation: Maonan Wang, et al. Mol Med Rep. 2022 Oct;26(4):312.
year: '2022'

doi: 10.3892/mmr.2022.12828
journal_title: Molecular Medicine Reports
journal_nlm_ta: Mol Med Rep
publisher_name: D.A. Spandidos

keywords:
- oridonin
- ulcerative colitis
- Sirt1/NF-κB/p53 pathway
- dextran sulfate sodium

---
